| Bio-Link News |
|
19/7/2017 – Bio-Link Executive Director, Christopher Boyer, is attending the 2017 Bioshares Biotech Summit in Queenstown from the 20-22nd of July. 17/7/2017 – Bio-Link Business Development Associate, Dr Lieven Huang, is attending the 2017 ‘Business of Regenerative Medicine’ in Toronto…more 06/6/2017 – Bio-Link Senior Business Development Associate, Dr Gorjana Mitic, has been selected to participate in the Bridge Program…more 23/5/2017 – Bio-Link has been engaged by Kunovus Technologies to facilitate partnering of KT009…more |
| Client News |
|
20/07/2017 – Oncology Venture receives option right to execute licence for clinical-stage cancer therapeutic from Novartis…more 10/07/2017 – First Dosing in a Phase 1b Combination Trial of the Dynamin Inhibitor Prochlorperazine…more 07/06/2017 – Oncology Venture: new APO010 multiple myeloma trial initiation, clinical and patent strategy validation …more |
| Industry News |
|
Thu, Jul 20, 2017
Source: BioSpace |
| Welcome to Bio-Link |
|
Bio-Link is a strategic consulting and biotechnology business development company that works with Australian and international life sciences companies and academic institutions to facilitate deals based on strategic technology analysis and consulting, business development, project management and deal negotiation. Bio-Link also provides technology scouting and representation services for Australian and international companies. Bio-Link has offices in Melbourne and Sydney. Please explore our website to learn more about Bio-Link’s services and client endorsements and our portfolio of client technologies. Follow @BioLinkAus |
Bio-Link employs PatSnap IP Analytics |
Bio-Link is a proud member of
|
